Tag:
Bellicum Pharmaceuticals
Latest Headlines
Latest Headlines
Bellicum snags $20M for mid-stage cancer vaccine program
Bellicum Pharmaceuticals says it has rounded up a $20 million round to back work on an experimental cancer vaccine.
Bellicum receives $5.7M in funding for CaspaCIDe
Houston, TX-based biotech Bellicum Pharmaceuticals gained a $5.7 million influx of cash to continue testing and manufacturing its cancer therapy, CaspaCIDe. The therapy is being tested for Graft
